期刊
NPJ BREAST CANCER
卷 3, 期 -, 页码 -出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41523-017-0040-8
关键词
-
类别
资金
- National Cancer Institute of the National Institutes of Health [U10CA180821, U10CA180882, UG1CA189823, U10CA180820, U10 CA189828, U10 CA180820, U10CA180868, 10CA180888, UG1CA189974, U10CA180863]
- CCSRI grant [703547]
- Susan G. Komen Foundation
- American Cancer Society
- Breast Cancer Research Foundation
- Nestle Health Sciences
- Harvard University Press
- Ozeri Corporation
- NATIONAL CANCER INSTITUTE [UG1CA189823, UG1CA189974, U10CA180821, U10CA180867, U10CA180882] Funding Source: NIH RePORTER
Excess body weight is a poor prognostic factor in women with early breast cancer, but the effect of weight loss on the risk of breast cancer recurrence and mortality in women who are overweight or obese at the time of breast cancer diagnosis has not been evaluated. The Alliance for Clinical Trials in Oncology Breast Cancer Weight Loss trial, also known as A011401, is testing the impact of a telephone-based weight loss program on invasive disease-free survival in 3136 women with a body mass index >= 27 kg/m(2) who have recently been diagnosed with stage II-III, HER-2 negative breast cancer. Secondary outcomes of the trial include the impact of the weight loss intervention on overall survival, body weight, physical activity, dietary intakes, incidence of comorbidities, serum biomarkers and patient reported outcomes. Participants are randomized 1:1 to a 2-year, telephone-based weight loss intervention or to an education control group. The intervention is delivered through 42 telephone calls, delivered by health coaches based at the Dana-Farber Cancer Institute. Calls are supplemented by an intervention workbook, as well as a number of tools to help facilitate weight loss. Intervention goals include loss of 10% of baseline body weight, achieved through caloric restriction and increased physical activity. This large-scale study testing the impact of purposeful weight loss after cancer diagnosis on the risk of breast cancer recurrence and mortality has the potential to make weight loss programs a standard part of breast cancer treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据